Professor Feng Qinfu (CAMS Cancer Hospital) Visits for Radiotherapy Consultations & Teaching

Professor Feng Qinfu (CAMS Cancer Hospital) Visits for Radiotherapy Consultations & Teaching

In the heat of July, a high‑level academic and clinical event brought top‑tier national radiotherapy expertise to the inpatient wards of the Lanzhou Campus of Gansu Wuwei Cancer Hospital. On July 28, Professor Feng Qinfu from the Department of Radiation Oncology at the Cancer Hospital, Chinese Academy of Medical Sciences, made a dedicated visit to the Lanzhou Campus to carry out a full range of clinical and academic activities — including routine consultations, ward rounds, complex case discussions, specialized lectures, and hands‑on technical guidance. By introducing cutting‑edge concepts in thoracic tumor radiotherapy to the Gansu region, Professor Feng helped advance the radiotherapy discipline at the Lanzhou Campus, bringing nationally recognized cancer care services directly to residents of Northwest China.

Professor Feng Qinfu is a leading authority in thoracic tumor radiotherapy in China, with more than 40 years of experience in clinical practice, research, and education in radiation oncology. He holds a master's degree from Peking Union Medical College and pursued advanced training at Duke University Medical Center in the United States. His clinical and research focus areas include comprehensive radiotherapy for lung cancer, esophageal cancer, and thymoma; three‑dimensional conformal radiotherapy; prevention and management of radiation‑induced lung injury; and dose‑reduction strategies in hypofractionated precision radiotherapy. He has published over 70 academic papers, contributed to 8 oncology monographs, and received multiple national and provincial research awards, including the Huaxia Medical Science and Technology Award and the Beijing Science and Technology Progress Award. Professor Feng has developed a distinctive clinical approach to dose sparing of the spinal cord, heart, and lungs, optimization of stereotactic body radiotherapy, and combined heavy ion‑photon therapy. He serves as a technical advisor to multiple cancer centers across China. During his visit to the Lanzhou Campus, he brought decades of clinical expertise and cutting‑edge research findings to comprehensively support the advancement of the campus's radiotherapy discipline.

Thorough Consultations Bring Warmth, Bedside Care Reflects True Compassion

Upon arriving at the radiotherapy ward, Professor Feng Qinfu reviewed all current inpatient records with the medical and nursing team, identifying challenging thoracic tumor cases, patients suitable for combined heavy ion‑photon therapy, and special cases involving radiation‑induced lung injury or esophageal mucosal reactions, establishing the priorities for the ward round.

Throughout the rounds, Professor Feng maintained a calm and compassionate manner, listening attentively to each patient's concerns. For an elderly patient with advanced lung cancer experiencing chest tightness and shortness of breath after heavy ion radiotherapy, he carefully reviewed the imaging findings, inquired in detail about the patient's diet, cough, and sleep, and adjusted the radiotherapy fractionation scheme based on the patient's weight and cardiopulmonary tolerance — instructing the attending physician on refining the target volume protection strategy. For a patient with esophageal cancer experiencing swallowing pain and mucosal injury after concurrent chemoradiotherapy following surgery, he personally assessed the patient's eating status, explained key points in mucosal protection and care, and adjusted nutritional support and symptomatic treatment accordingly.

Beijing‑Gansu Collaboration Deepens, Strengthening the Northwest Heavy Ion Therapy Hub

Professor Feng Qinfu has maintained a regular presence at the Lanzhou Campus, traveling between Beijing and Lanzhou on an ongoing basis. Through consultations, teaching, and academic guidance, he has consistently supported the hospital's discipline development, enabling local patients to access top‑tier specialist care without having to travel to Beijing.

Going forward, the hospital will continue to strengthen its collaborative mechanism with nationally recognized experts through regular on‑site engagement. It will further develop its specialized capabilities in precision heavy ion radiotherapy, promote deeper integration of photon radiotherapy, heavy ion therapy, targeted therapy, immunotherapy, and palliative care, and leverage top‑tier talent to drive disciplinary growth. Through advanced technology and compassionate care, the hospital is committed to safeguarding health and serving the community, continuously improving a comprehensive, whole‑life‑cycle cancer care system that covers the Hexi region and reaches across the province — ensuring that people in Gansu can access world‑class radiotherapy and oncology services without leaving their home region.

Writer: Liu Qiong

First Review: Liu Qiong

Second Review: Guo Yishan

Third Review: Cai Qinghua